Related Experiment Videos
Short- and long-term dobutamine treatment in chronic ischemic heart failure
Insights
Dobutamine improved heart function in heart failure patients short-term, but long-term use showed diminishing returns in ejection fraction. This study highlights the transient benefits of dobutamine in coronary artery disease patients.
Area of Science:
- Cardiology
- Pharmacology
- Medical Imaging
Background:
- Chronic congestive heart failure (CHF) secondary to coronary artery disease (CAD) significantly impairs cardiac function.
- Dobutamine is a common inotrope used to manage heart failure, but its short- and long-term effects require detailed characterization.
Purpose of the Study:
- To evaluate the short-term (1 hour) and long-term (72 hours) hemodynamic and regional ejection fraction effects of dobutamine in CHF patients with CAD.
- To assess changes in cardiac output, heart rate, peripheral resistance, and ejection fraction using radionuclear angiography.
Main Methods:
- Patients with CHF due to CAD received intravenous dobutamine (8.5 μg/kg/min).
- Hemodynamic and regional ejection fraction parameters were measured at baseline, 1 hour, and 72 hours using radionuclear angiography (MUGA and first-pass techniques).
Main Results:
- Short-term dobutamine administration significantly increased heart rate and cardiac index, while decreasing peripheral resistance (p < 0.001).
- Global left ventricular ejection fraction (LVEF) increased significantly at 1 hour (21.8% to 25%, p < 0.02).
- Long-term (72 hours) dobutamine infusion maintained elevated heart rate and cardiac index but regional ejection fraction returned to baseline levels, though global LVEF in one view remained elevated.
Conclusions:
- Dobutamine provides significant short-term hemodynamic and ejection fraction benefits in CHF patients with CAD.
- The beneficial effects on ejection fraction appear to diminish with continuous long-term infusion, suggesting limited sustained efficacy.
Abstract:
This study was undertaken in order to characterize the short-term (1 hour) and long-term (72 hours) effect of dobutamine on hemodynamic and regional ejection fraction parameters measured by radionuclear angiography in patients with chronic congestive heart failure due to coronary artery disease. Baseline hemodynamic and radionuclear parameters were measured and then intravenous dobutamine (8.5 mu/kg/min) was administered. The above parameters were determined again after 1 hour and 72 hours of continuous dobutamine administration. Sixty minutes (short-term) after dobutamine administration heart rate and cardiac index increased significantly (p less than 0.001 for both) and peripheral resistance decreased concomitantly (p less than 0.005). Global left ventricular ejection fraction (LVEF) as measured by multigated equilibrium nuclear angiography (MUGA) increased from 21.8 +/- 10.6% to 25 +/- 13.5 (p less than 0.02). Count-based mean regional ejection fraction in the septal, inferoapical, posterolateral (45 degrees left anterior oblique view) and inferior apical and anterolateral (30 degree right anterior oblique gated first pass) regions increased also. At 72 hours (long-term) after continuous dobutamine infusion, heart rate and cardiac index were still significantly higher and peripheral resistance lower than in the control study. However, global and count-based regional ejection fraction decreased to control values in the right anterior oblique view (first-pass analysis) and the left anterior oblique view (MUGA). Global LVEF measured in the right anterior oblique view by first-pass technique was significantly higher than control in the long-term study (23 +/- 9.7 vs. 27.8 +/- 2.4; p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)